<DOC>
	<DOCNO>NCT02311244</DOCNO>
	<brief_summary>This observational study aim identify new molecular promoter mortality ( morbidity ) patient type 2 diabetes mellitus ( T2DM ) .</brief_summary>
	<brief_title>The Sapienza University Mortality Morbidity Events Rate ( SUMMER ) Study Diabetes</brief_title>
	<detailed_description>Background Mortality rate diabetic patient twice much non-diabetic individual similar age ; make diabetes lead risk factor mortality , especially cardiovascular origin , account 2.9 million global event yearly . Such scenario expect deteriorate , give prevalence type 2 diabetes mellitus ( T2DM ) , far common form diabetes comprise 90 % diabetic individual , increase worldwide . Predicting devastating event , therefore , urgently need order target aggressive prevention strategy high risk T2DM patient . Aims This observational study aim identify new molecular promoter all-cause mortality patient T2DM . Secondary endpoint identify individual molecular marker - cardiovascular mortality ; - myocardial infarction ; - stroke ; - dialysis . Other pre-specified endpoint assess subject : - LADA ; - severe hypoglycemic episode ; - revascularization procedure ; - hospitalization heart failure ; - co-morbidities ( cancer - follow-up , liver disease , chronic obstructive pulmonary disease , autoimmune endocrine disorder , - non-diabetic - renal disease , fracture , cognitive impairment ) . Patients A total 5,000 patient T2DM sex recruit . Measures The following parameter record exposure variable baseline . - Age , BMI , waist circumference , systolic diastolic pressure ; - Lifestyle habit , include diet , physical activity ( validated questionnaire ) smoking . - Menopausal state ( woman ) . - Family history diabetes ( 3 consecutive generation ) . - Family history cardiovascular disease ( first degree relative ) . - Diabetes duration . - Severe ( require assistance ) hypoglycemic episode ( per year ) . - Myocardial infarction , stroke , ulcer/gangrene/amputation , coronary peripheral revascularization , hospitalization heart failure , dialysis ( follow-up ) . - Glucose , HbA1c , creatinine , uric acid , total HDL cholesterol , triglyceride , high sensitive C reactive protein , testosterone , Vitamin D , uric acid level , white blood cell counting , urinary albumin creatinine ratio ( ACR ) - Current glucose- , lipid- , blood pressure-lowering anti-platelet anti-coagulant treatment . - Other relevant treatment ( steroid , NSAIDs , immunomodulators , androgen , estrogen , anti-fracturative therapy ) . - Main co-morbidities ( cancer , chronic liver disease , chronic obstructive pulmonary disease , autoimmune endocrine disorder , - non-diabetic - renal disease , fracture , cognitive impairment ) . The following parameter assess baseline : - GADAs ( radiobinding assay use vitro translate [ 35S ] methionine-labelled GAD65 ) IA-2 antibody ( radioimmunoprecipitation assay ) identify subject LADA . - Genomic ( common rare variant gene interest accord pathway-centric approach mean Affymetrix platform ) , transcriptomic ( differential level mRNA GeneChip Human Gene 1.0 ST Array Affymetrix ) metabolomic combination ultra-pressure liquid chromatography gas chromatography couple mass spectrometry ) analysis . Measurements testosterone , Vitamin D , GADAs IA-2 antibody well gnomic , transcriptomic metabolomic analysis centralize . Time schedule Recruitment patient last approximately 3 year . The enrolled patient follow least 5 year yearly visit telephone call consultation death record case drop-out unknown reason .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Type 2 diabetes mellitus Severe psychiatric illness Endstage renal disease dialysis Cirrhosis Any active cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>All-cause mortality</keyword>
	<keyword>Cardiovascular mortality</keyword>
	<keyword>Myocardial infarction</keyword>
	<keyword>Stroke</keyword>
	<keyword>Dialysis</keyword>
</DOC>